Trials / Completed
CompletedNCT02421601
A Study of SI-6603 in Patients With Lumbar Disc Herniation
A Multicenter, Open-label Study of SI 6603 in Patients With Lumbar Disc Herniation (Phase III)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,011 (actual)
- Sponsor
- Seikagaku Corporation · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of SI-6603(Condoliase) in patients with lumbar disc herniation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Condoliase | 1.25 U, intradiscal injection, one time |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2015-04-20
- Last updated
- 2023-03-23
- Results posted
- 2021-11-11
Locations
48 sites across 4 countries: United States, Germany, Romania, Spain
Source: ClinicalTrials.gov record NCT02421601. Inclusion in this directory is not an endorsement.